News

Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead

VRTX

Vertex’s Crinetics Deal Balances Growth with Integration RiskVertex Pharmaceuticals (NASDAQ:VRTX) is continuing to broaden its business beyond cystic fibrosis, with its renal medicine portfolio, rare endocrine assets and cell therapies among the company’s priorities, CEO and Pres

Why are there concerns AI could threaten humanity, and how real are they?

Existential fears about AI have once again reared their head - here's what you need to know.

Temporal CEO on AI safety concerns: We should 'absolutely' audit what the agents have been doing

Samar Abbas, Temporal co-founder and CEO, joins ‘Squawk Box’ to discuss what the company does, its Series E funding round bringing its valuation to $12.55B, and shares his perspective on AI safety concerns.

Stocks making the biggest moves premarket: Intel, Marvell, CrowdStrike & more

INTC, INTCN, INTCCL, INL, INLD, INTCUS, INTC1, INTC0, INTCCL1, INTCCL0

These are the stocks posting the largest moves premarket.

UGI's Strong Dividend History Helps Get It To The Top 10

UGI

UGI Corp. (Symbol: UGI) has been named as a Top 10 dividend paying utility stock, according to Dividend Channel, which published its weekly ''DividendRank'' report. The report noted that among utilities, UGI shares displayed both attractive valuation metrics and strong profita

General Motors has an 'underappreciated' growth driver, UBS says

UBS

The investment bank has a buy rating on the automotive stock.

NTAP Crosses Above Average Analyst Target

NTAP

In recent trading, shares of NetApp, Inc. (Symbol: NTAP) have crossed above the average analyst 12-month target price of $195.18, changing hands for $199.28/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua

Ericsson Reaches Analyst Target Price

ERIC

In recent trading, shares of Ericsson (Symbol: ERIC) have crossed above the average analyst 12-month target price of $10.23, changing hands for $10.31/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

Kohl's Reaches Analyst Target Price

KSS

In recent trading, shares of Kohl's Corp. (Symbol: KSS) have crossed above the average analyst 12-month target price of $16.85, changing hands for $17.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

College students feel more pressure to be perfect. Experts explain why

PERF

College students report rising perfectionism. Researchers point to economic pressure and inequality, while experts cite social comparison.